| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.33 | 9e-18 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-16 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-16 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-13 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-13 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |